Header Logo

Connection

Nirav Shah to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications Nirav Shah has written about Maximum Tolerated Dose.
Nirav Shah
Connection Strength
0.055
Maximum Tolerated Dose
  1. Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer Therapy. Clin Pharmacol Ther. 2025 Jan; 117(1):34-55.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.